Leadership & Scientific Advisory Board

Making cancer more detectable.

Management Team

Geoff Hollis

CFO and Company Secretary

Geoff recently spent two years as CFO and Company Secretary of Victory Offices Limited, a leading provider of flexible workspace solutions, leading the company through an IPO on the Australian Stock Exchange.

Geoff Hollis

CFO and Company Secretary

Geoff recently spent two years as CFO and Company Secretary of Victory Offices Limited, a leading provider of flexible workspace solutions, leading the company through an IPO on the Australian Stock Exchange.
Marie Zhang

Marie Zhang

VP Research & Pre-Clinical Development

Marie Zhang, PhD, MBA, is a problem-solver and an effective scientific leader specializing in pharmaceutical and research reagent product development.
Marie Zhang

Marie Zhang

VP Research & Pre-Clinical Development

Marie Zhang, PhD, MBA, is a problem-solver and an effective scientific leader specializing in pharmaceutical and research reagent product development.

Experienced Board

Commercially focused team with deep industry & clinical experience.

Robert Proulx

Executive Chairman

Robert is an operationally oriented executive with over 30 years in life science & medical device product development & commercialization and has led the company through recent restructuring and recapitalization efforts.

Robert Proulx

Executive Chairman

Robert is an operationally oriented executive with over 30 years in life science & medical device product development & commercialization and has led the company through recent restructuring and recapitalization efforts.
Michael Harsh

Michael Harsh

Non-Executive Director

Mike has over 36 years of experience in healthcare technology, focused on diagnostic imaging having served as Vice President and Chief Technology Officer for GE Healthcare.
Michael Harsh

Michael Harsh

Non-Executive Director

Mike has over 36 years of experience in healthcare technology, focused on diagnostic imaging having served as Vice President and Chief Technology Officer for GE Healthcare.
David Ludvigson

David Ludvigson

Non-Executive Director

David is a financial and operating executive with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems.
David Ludvigson

David Ludvigson

Non-Executive Director

David is a financial and operating executive with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems.

Dianne Angus

Non-Executive Director

Dianne has worked as a senior executive within the biotechnology, agritech and healthcare sectors for over twenty years and currently serves as non-executive director with Neuren Pharmaceuticals Limited (ASX:NEU) and the federal government Grains Research & Development Corporation (GRDC).

Dianne Angus

Non-Executive Director

Dianne has worked as a senior executive within the biotechnology, agritech and healthcare sectors for over twenty years and currently serves as non-executive director with Neuren Pharmaceuticals Limited (ASX:NEU) and the federal government Grains Research & Development Corporation (GRDC).
Mark Van Asten

Mark Van Asten

Non-Executive Director

Mark has over 30 years of experience in the medical diagnostics and life science industry. Much of this time has been specific to international business development, strategic planning and introduction of new technology.
Mark Van Asten

Mark Van Asten

Non-Executive Director

Mark has over 30 years of experience in the medical diagnostics and life science industry. Much of this time has been specific to international business development, strategic planning and introduction of new technology.
Jovanka Naumoska

Jovanka Naumoska

Non-Executive Director

Jovanka is an Australian legal practitioner with expertise in intellectual property law, corporate law, and corporate governance.
Jovanka Naumoska

Jovanka Naumoska

Non-Executive Director

Jovanka is an Australian legal practitioner with expertise in intellectual property law, corporate law, and corporate governance.

Scientific Advisory

Collective expertise in oncology, medical imaging, nanotechnology, clinical trial design.

John Hazle

Dr. John Hazle

Chairman, Department of Imaging Physics, MD Anderson Cancer Center

John chairs the scientic advisory board. He is board certifed in medical physics with 30 years in pre-clinical & clinical imaging research. He chairs Cancer Research at UT Graduate School of Biomedical Sciences.
Lisa Horvath

Prof. Lisa Horvath

Director, Department of Medical Oncology, Chris O’Brien Lifehouse

She has an active clinical practice and is involved with a large number of clinical trials in prostate and colorectal cancers in addition to phase I trial work.
Robert Ivkov

Dr. Robert Ivkov

Assistant Professor, Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine

Dr. Ivkov’s research focuses on the development and characterization of magnetic nanoparticles and AMF-devices for cancer therapy.
Andrew Scott

Prof. Andrew Scott

Director, Department of Molecular Imaging and Therapy, Austin Health

His clinical and research interests are focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies, and in molecular imaging particularly oncology applications in PET in staging cancer.
Paul Grint

Dr. Paul Grint

Chairman, The Innovation Council

Dr. Grint has more than two decades of experience in biologics and small molecule research and development, including the successful approval and commercialization of products in the infectious diseases, immunology and oncology therapeutic areas.

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.